Brett A. Wall - 18 Jun 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Pres Neuroscience
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
18 Jun 2021
Net transactions value
-$42,379
Form type
4
Filing time
22 Jun 2021, 17:58:36 UTC
Previous filing
02 Jun 2021
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $87,413 +1,168 +5.4% $74.84 22,655 18 Jun 2021 Direct F1
transaction MDT Ordinary Shares Tax liability $115,590 -938 -4.1% $123.23 21,717 18 Jun 2021 Direct F1
transaction MDT Ordinary Shares Sale $14,202 -115 -0.53% $123.50 21,602 21 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1,168 -15% $0.000000 6,850 18 Jun 2021 Ordinary Shares 1,168 $74.84 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.